The Peter Zeihan Podcast Series India Complicates the US Fentanyl Crisis || Peter Zeihan
7 snips
Apr 11, 2025 The latest analysis reveals a shocking shift in the fentanyl supply chain, with India emerging as a key source for precursor chemicals. This change complicates the U.S. strategy for tackling the fentanyl crisis. Experts emphasize the need for a new approach, urging a focus on reducing demand instead of just cutting off supply. The discussion highlights the ongoing challenges in global drug manufacturing and policy responses to public health crises.
AI Snips
Chapters
Transcript
Episode notes
Fentanyl vs. Cocaine Production
- Fentanyl, a synthetic opioid, requires significantly less effort to produce than cocaine, which is plant-derived.
- This efficiency in production contributes to its widespread availability and poses unique challenges for drug control efforts.
U.S. Fentanyl Control Strategy
- The U.S. attempts to control fentanyl by pressuring precursor material suppliers and countries with drug labs.
- However, focusing solely on these aspects overlooks the more crucial points in the supply chain.
Data Lag and Shifting Supply Chains
- Drug data often lags by two years, making timely intervention difficult.
- India's recent emergence as a precursor supplier highlights the dynamic nature of the fentanyl trade.